Patents by Inventor Milind S. Shintre

Milind S. Shintre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9421263
    Abstract: The present invention relates to compositions comprising quaternary ammonium compounds and essential oils or individual constituents thereof which exhibit enhanced antimicrobial effects. Such combinations may be comprised in lotions, gels, creams, soaps, etc. for application to skin or mucous membranes. The invention is based, at least in part, on the observation that synergistic antimicrobial effects are achieved with combinations of essential oils or individual constituents thereof and low concentrations of quaternary ammonium compounds.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: August 23, 2016
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Shanta M. Modak, Milind S. Shintre, Trupti Gaonkar, Lauserpina Caraos
  • Patent number: 7951840
    Abstract: The addition of low concentrations of combinations of water-soluble organic salts of zinc to gels, creams, lotions or ointments can increase the ability of these products to reduce or prevent exogenous irritants from causing irritation of the underlying substrate. The addition of low concentrations of combinations of water-soluble organic zinc salts to these gels, creams, lotions or ointments also can reduce the irritation of skin or mucous membranes caused by the addition of potentially-irritating substances such as spermicides, microbicides, fungicides or other therapeutic agents to the gel, cream, lotion or ointment. The advantages of this anti-irritant approach over others, which generally employ high concentrations of single zinc salts, are the reduced potential for zinc toxicity, the reduced potential for toxicity related to zinc itself, and the preservation of the desirable biological properties of potentially-irritating therapeutic substances added to the gel, cream, lotion or ointment.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: May 31, 2011
    Inventors: Shanta M. Modak, Milind S. Shintre, Lauser Caraos, Trupti Gaonkar
  • Publication number: 20110070316
    Abstract: The present invention relates to compositions comprising quaternary ammonium compounds and essential oils or individual constituents thereof which exhibit enhanced antimicrobial effects. Such combinations may be comprised in lotions, gels, creams, soaps, etc. for application to skin or mucous membranes. The invention is based, at least in part, on the observation that synergistic antimicrobial effects are achieved with combinations of essential oils or individual constituents thereof and low concentrations of quaternary ammonium compounds.
    Type: Application
    Filed: November 29, 2010
    Publication date: March 24, 2011
    Inventors: Shanta M. Modak, Milind S. Shintre, Trupti Gaonkar, Lauserpina Caraos
  • Patent number: 7871649
    Abstract: The present invention relates to compositions comprising quaternary ammonium compounds and essential oils or individual constituents thereof which exhibit enhanced antimicrobial effects. Such combinations may be comprised in lotions, gels, creams, soaps, etc. for application to skin or mucous membranes. The invention is based, at least in part, on the observation that synergistic antimicrobial effects are achieved with combinations of essential oils or individual constituents thereof and low concentrations of quaternary ammonium compounds.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: January 18, 2011
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Shanta M. Modak, Milind S. Shintre, Trupti Gaonkar, Lauserpina Caraos
  • Patent number: 7745425
    Abstract: The present invention relates to methods and compositions which employ low concentrations of combinations of zinc salts to prevent the irritation of skin or mucous membranes that may be caused by therapeutic agents, by personal hygiene products, by articles such as gloves or condoms, or by various physical, chemical, mechanical, or biological irritants.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: June 29, 2010
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Shanta M. Modak, Milind S. Shintre, Lauserpina Caraos, Trupti Gaonkar, Ingrid Geraldo
  • Publication number: 20040102429
    Abstract: The addition of low concentrations of combinations of water-soluble organic salts of zinc to gels, creams, lotions or ointments can increase the ability of these products to reduce or prevent exogenous irritants from causing irritation of the underlying substrate. The addition of low concentrations of combinations of water-soluble organic zinc salts to these gels, creams, lotions or ointments also can reduce the irritation of skin or mucous membranes caused by the addition of potentially-irritating substances such as spermicides, microbicides, fungicides or other therapeutic agents to the gel, cream, lotion or ointment. The advantages of this anti-irritant approach over others, which generally employ high concentrations of single zinc salts, are the reduced potential for zinc toxicity, the reduced potential for toxicity related to zinc itself, and the preservation of the desirable biological properties of potentially-irritating therapeutic substances added to the gel, cream, lotion or ointment.
    Type: Application
    Filed: July 17, 2003
    Publication date: May 27, 2004
    Inventors: Shanta M. Modak, Milind S. Shintre, Lauser Caraos, Trupti Gaonkar
  • Patent number: RE45435
    Abstract: The addition of low concentrations of combinations of water-soluble organic salts of zinc to gels, creams, lotions or ointments can increase the ability of these products to reduce or prevent exogenous irritants from causing irritation of the underlying substrate. The addition of low concentrations of combinations of water-soluble organic zinc salts to these gels, creams, lotions or ointments also can reduce the irritation of skin or mucous membranes caused by the addition of potentially-irritating substances such as spermicides, microbicides, fungicides or other therapeutic agents to the gel, cream, lotion or ointment. The advantages of this anti-irritant approach over others, which generally employ high concentrations of single zinc salts, are the reduced potential for zinc toxicity, the reduced potential for toxicity related to zinc itself, and the preservation of the desirable biological properties of potentially-irritating therapeutic substances added to the gel, cream, lotion or ointment.
    Type: Grant
    Filed: November 9, 2012
    Date of Patent: March 24, 2015
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Shanta M. Modak, Milind S. Shintre, Lauserpina Caraos, Trupti Gaonkar